tiprankstipranks
ZyVersa Therapeutics (ZVSA)
NASDAQ:ZVSA
US Market

ZyVersa Therapeutics (ZVSA) Income Statement

Compare
171 Followers

ZyVersa Therapeutics Income Statement

Last quarter (Q3 2024), ZyVersa Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, ZyVersa Therapeutics's net income was $-2.40B. See ZyVersa Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -10.40K$ -10.40K$ -10.40K$ -10.40K
Operating Expenses
$ 14.41M$ 13.01M$ 7.70M$ 11.83M
Depreciation and Amortization
$ 10.40K$ 10.40K$ 10.40K$ 10.40K
EBITDA
$ -107.74M$ -11.67M$ -7.25M$ -12.16M
Operating Income
$ -14.42M$ -13.01M$ -7.70M$ -11.83M
Other Income/Expenses
$ -93.33M$ -2.37M$ -379.79K$ -850.11K
Pretax Income
$ -107.75M$ -14.05M$ -8.08M$ -12.68M
Net Income
$ -98.30M$ -759.10M$ -8.91M$ -13.20M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -1.09K$ -930.25$ -173.66$ -272.45
Diluted EPS
$ -1.09K$ -930.25$ -173.66$ -272.45
Weighted Average Shares Outstanding
97.50K 25.95K 46.55K 46.55K
Weighted Average Shares Outstanding (Diluted)
97.50K 25.95K 46.55K 46.55K
Currency in USD

ZyVersa Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis